PTGS2 and breast carcinoma: Doxorubicin-resistant MCF-7 cells (MCF-7/DOX), which exhibit high invasiveness, strongly express COX-2 similar to that expressed in the highly metastatic breast cancer MDA-MB-231 cells (Kang et al., 2011).